Navigation Links
Metamark Appoints Cornelius J. Merlini Chief Commercial Officer
Date:10/1/2013

CAMBRIDGE, Mass., Oct. 1, 2013 /PRNewswire/ -- Metamark Genetics, Inc., a leader in the discovery of molecular prognostic and diagnostic tests for cancer, today announced that Cornelius J. Merlini, former general manager of HealthTronics Laboratory Solutions (HLS), has been appointed Metamark's Senior Vice President and Chief Commercial Officer.  In August 2013, Metamark acquired HLS, a national uropathology laboratory, from Endo Health Solutions, Inc.  Mr. Merlini will report to Metamark President and Chief Executive Officer, Shawn M. Marcell, and will join the company's senior leadership team.

"We are pleased that Cornelius has joined Metamark.  His exceptional leadership, commercial acumen, and track record bringing paradigm-changing products to market have produced transformational business growth," said Mr. Marcell.  "Cornelius already is an established leader of Metamark's newly-acquired uropathology business, where he assembled a talented, dedicated team – including a specialized national field sales force.  This commercial team nicely complements Metamark's innovative research and development efforts, and will accelerate the launch of ProMark™, our novel prostate cancer prognostic test."

"Metamark's strong science engine fits perfectly with its new commercial and operational machine," said Mr. Merlini.  "ProMark™ could redefine the management of early stage prostate cancer and become a standard test sought by patients and ordered by urologists when making well-informed treatment decisions.  It is exciting to join a company that could change the way prostate cancer is treated." 

Mr. Merlini has over twenty-five years of life science experience across a wide array of functions and businesses.  Prior to HealthTronics Lab Solutions, Mr. Merlini was SVP, Commercial Operations at Cord Blood Registry, a market leader in cord blood stem cell banking.  He spent ten years with increasing marketing, management and franchise leadership responsibilities at Johnson & Johnson, where he served most recently as Worldwide Vice-President of the cardiovascular franchise for Johnson & Johnson's biopharmaceutical business.  Earlier, Mr. Merlini gained successful sales and sales leadership experience with Marion Laboratories (now Sanofi-Aventis). 

About Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based prognostic and diagnostic tests aimed at improving cancer care.  The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon and breast cancers.  In early 2014, Metamark plans to commercialize ProMark™ – its prostate cancer prognostic test – through its Cambridge, Massachusetts CLIA-certified laboratory.  For more information, please visit the company's Website at www.metamarkgenetics.com.  Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.


'/>"/>
SOURCE Metamark Genetics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
2. ACTUS Appoints New Members to Its Management Team
3. Immune Design Appoints Stephen R. Brady Chief Business Officer
4. DiaVacs, Inc. Appoints Orville Kolterman, M.D. As Chief Medical Officer
5. Sanomedics International Holdings, Inc. appoints new Chairman of the Board and installs new Director of Business Development.
6. Solulink Appoints Life Science Industry Veteran Jack Ball as Chief Executive Officer
7. Cold Spring Harbor Laboratory Appoints Teri F. Willey to Accelerate Commercialization Efforts
8. Senn Chemicals Appoints New Chief Executive Officer
9. Novelda Appoints Alf-Egil Bogen as Chief Executive Officer to Lead the Company to the Next Level
10. Creabilis Appoints Professor Gil Yosipovitch and Professor Praveen Anand to its Scientific Advisory Board
11. Alexander Proudfoot Appoints Executive Vice President for Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... Spyker, PhD, MD former Acting Deputy Director in the FDA CDRH Division of ... Staff has joined the company as an Expert Consultant. , In Dr. Spyker’s ...
(Date:2/21/2017)... , Feb. 21, 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or ... operational results for the three months ended December 31, 2016. ... -based life sciences and diagnostics company that develops and commercializes ... ... to build on the commercial milestones achieved in fiscal 2016," ...
(Date:2/21/2017)... ... February 21, 2017 , ... The medical potential of stem cells is both ... of medicine, due to their differentiating characteristics. Stem cells are unique as the have ... be induced to become tissue or organic-specific cells with special functions. , Stem ...
(Date:2/21/2017)... 2017  Lexus, a returning partner of the Amgen Tour ... exclusive automobile partner of the men,s and women,s events for the ... 2017 Amgen Tour of California will mark ... the best professional cycling teams in the world racing from Northern ... Amgen Breakaway from Heart Disease TM Women,s Race ...
Breaking Biology Technology:
(Date:2/3/2017)... , Feb. 3, 2017 A new independent ... Strategy Partners, LLP (IdSP) . Designed to fill a ... complex identity market, founding partners Mark Crego ... combined years just in identity expertise that span federal ... non-profit leadership. The Crego-Kephart combined expertise has a common ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/24/2017)... Jan. 24, 2017 Biopharm Reports has ... laboratory use of nuclear magnetic resonance spectroscopy (NMR). ... and profiled current practices, developments, trends and end-user ... as growth and opportunities. These areas include growth ... instruments, needs and innovation requirements, hyphenated NMR techniques, ...
Breaking Biology News(10 mins):